Exelixis
$57.94Change from previous close: −0.80%Absolute change: −$0.47
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $14.36B
- Enterprise value
- $13.68B
- P/E (trailing 12 months)
- 18.2
- Forward P/E
- 13.6
- PEG
- 2.56
- Price/book
- 7.82
- Price/sales
- 5.89
- EV/EBITDA
- 13.4
- EV/revenue
- 5.62
Profitability and growth
- Gross margin
- 96.5%
- Operating margin
- 39.5%
- Net margin
- 35.3%
- ROE
- 44.4%
- ROA
- 24.0%
- Revenue growth (year over year)
- 10.6%
- Earnings growth (year over year)
- 26.2%
Financial health
- Total cash
- $839.39M
- Total debt
- $165.93M
- Debt/equity
- 0.09
- Current ratio
- 3.46
- Quick ratio
- 3.24
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $53.93
- Median price target
- $53.00
- High price target
- $66.00
- Low price target
- $41.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $4.26
- EPS estimate, current year
- $3.59
Shares and trading
- Beta
- 0.42
- Average volume
- 2.38M
- Shares outstanding
- 247.78M
- Float
- 213.6M
- Institutional ownership
- 106.8%
- Insider ownership
- 1.8%
- Short interest (% of float)
- 14.6%
- Short ratio (days)
- 12.8